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Abstract
Background: Mass-forming focal pancreatitis (FP) may mimic pancreatic cancer (PC) on magnetic
resonance (MR) imaging, and the preoperative differential diagnosis is often difficult. Recently, the
usefulness of diffusion-weighted imaging (DWI) in the diagnosis of pancreatic cancer has been reported in
several studies.
Purpose: To investigate if apparent diffusion coefficient (ADC) measurements based on diffusion-weighted
echo-planar imaging (DW-EPI) may distinguish between normal pancreas parenchyma, mass-forming focal
pancreatitis, and pancreas carcinoma.
Material and Methods:MRI was performed on 64 patients: 24 with pancreas carcinoma (PC), 20 with mass-
forming focal pancreatitis (FP), three patients with other focal pancreatic disease as well as 17 controls
without any known pancreatic disease. Diffusion-weighted sequence with ADC maps and T2-weighted
sequence for anatomical information was performed. Apparent diffusion coefficient (ADC) maps were
automatically created and analyzed using a dedicated user interface. In the group with pancreas disease the
abnormal parenchyma was detected by using T1- and T2-weighted images and the region of interest (ROI)
was transferred exactly to the ADC map and the coefficients were registered. In the control group the ROI
was set to the head of the pancreas followed by a similar registration of the ADCs.
Results: ADC values for mass-forming FP and PC differed significantly from ADC values for normal pancreas
parenchyma (P ¼ 0.001/P ¼ 0.002). Mean ADC values for mass-forming FP were 0.69+0.18  1023 mm2/s.
ADC values for PC were 0.78+0.11  1023 mm2/s, compared to ADC values of 0.17+0.06  1023 mm2/s
in the control group. However there was no significant difference in ADCs between PC and mass-forming FP
(P ¼ 0.15).
Conclusion: ADC measurements clearly differentiated between normal pancreatic tissue and abnormal
pancreas parenchyma (PC and mass-forming FP). However there is an overlap in values of PC and
mass-forming FP, with the consequent problem of their correct identification.
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Magnetic resonance imaging (MRI) along with MR cholan-
giopancreatography (MRCP) have become the imaging
modalities of choice to asses both the structure and the func-
tion of the pancreas. In addition, diffusion-weighted
imaging (DWI) has been shown to provide useful infor-
mation to discriminate between normal pancreas, pancreati-
tis, and pancreatic cancer (1). Diffusion-weighted MRI and
apparent diffusion coefﬁcient (ADC) measurements have
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been applied to the abdomen (2–5). The results suggest that
ADC measurements can be useful in the evaluation of
diffuse liver (6) and renal diseases (7, 8) as well as for char-
acterizing focal hepatic (4, 9), pancreatic (10–15), and renal
(16) lesions. The purpose of our study was to evaluate DWI
ﬁndings and measure the difference between ADC values of
normal pancreas parenchyma, mass-forming focal pancrea-
titis (FP) and pancreas carcinoma (PC). We chose these
pathologic conditions, as differentiation between them can
be difﬁcult. As there is a wide range of reported ADC
values (10, 17, 18) for PC and mass-forming FP we had to
establish our own reference values. Our aim was to test
whether there is a signiﬁcant difference in ADCs for
normal pancreas and abnormal pancreas parenchyma
(PC and mass-forming FP), as well as to test whether or
not it is possible to differentiate between PC and mass-
forming FP by using ADC measurements. This would
allow us to establish a non-invasive imaging of pancreatic
lesions protocol in the clinical routine to differentiate
between PC and mass-forming FP.
Material and Methods
Patients
In this prospective study 64 subjects were included.
Informed consent was obtained from all participants. The
PC group was composed of 24 patients (12 women and 12
men; age range 38–81 years, mean age 64 years) with histo-
logical proof of ductal adenocarcinoma (PC) through
Whipple procedure. Twenty patients (7 women and 13
men, age range 15–74 years, mean age 52 years) were
included in the mass-forming FP group. Sixteen of these
patients underwent surgery because malignancy could not
be ruled out by either imaging or ﬁne-needle aspiration.
In four patients mass-forming FP was diagnosed without
histopathologic proof, based on repeated imaging (MRI or
dynamic computed tomography) and clinical follow-up
(13–25 months) after the initial presentation. Seventeen sub-
jects without any pancreatic disease (5 women and 12 men;
age range 12–78 years, mean age 45 years) were included as
control group and had normal MRI/MRCP ﬁndings.
All patients underwent the same imaging protocol for the
diffusion-weighted imaging, and were scanned within 14
days prior to the surgery. Histological ﬁndings were deter-
mined from the records of our Department of Pathology. We
had to exclude three patients from our study due to the
following conditions: serous cyst adenoma (1), adenocarci-
noma of unknown primary localization (1), and diffuse
disease of intestine (measurement not possible) (1).
MR protocol
Diffusion-weighted sequence with ADC maps as well as the
routine pancreatic MR imaging protocol for anatomical
information were performed using a Magnetom Avanto
1.5 T scanner (Siemens Medical Solutions, Erlangen,
Germany) and a commercially available cp body phased
array coil. Diffusion-weighted images were acquired using
a single-shot echo-planar imaging pulse sequence in
expiration breath-hold. The following parameters were
used for the axial DW-EPI sequence: matrix size of 144 
192, a ﬁeld-of-view of 375  500 (pixel size 2.6  2.6 mm),
and a section thickness of 2.6 mm. The b factors used
were 50 and 500 s/mm2. In addition the routine pancreatic
MR imaging protocol for the patient group consisted of
TRUE-FISP imaging sequences, non-contrast T1-weighted
fat-suppressed and dynamic gadolinium-enhanced gradient-
echo imaging as well as magnetic resonance cholangiopan-
creatography (MRCP) and angiography (MRA). The ADC
maps were automatically created and analyzed using a
dedicated user interface (Leonardo, Siemens Medical
Solutions, Erlangen, Germany). The pancreas lesions were
detected using the T1- and T2-weighted images and the
ROI was transferred exactly to the ADC map and the
according coefﬁcients were registered (Figs. 1 and 2).
In the control group the ROI was set to the head of the pan-
creas gland followed by a similar registration of the ADCs.
In the diseased population ROIs ranged from 70 to 879 mm2
Fig. 1 A 69-year-old patient with a pancreatic adenocarcinoma of the head.
(a) Dynamic post-contrast pancreatic phase T1-weighted axial MR image, the
lesion shows heterogeneous hypo enhancing signal (large arrow), good depic-
tion of the slightly dilated main pancreatic duct (small arrow); (b) Axial ADC
map calculated from basis images obtained with b values of 50, 500 s/mm2
in the same patient clearly shows the lesion. On the ADC map, higher diffusion
is depicted as higher signal intensity
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(mean 354 mm2), whereas in the control group a ﬁxed ROI
of 100 mm2 was used.
Image analysis
Consensus reading was performed by two experienced radi-
ologists (15 years and 6 years of experience). ADCs were cal-
culated on a workstation with dedicated software. Signal
intensities on ADC maps were measured by using an
operator-deﬁned region of interest (ROI). ADCs were calcu-
lated for normal pancreas and focal lesions of the pancreas.
The ROIs for the pancreas were circular. Pancreas vessels,
the pancreatic duct and the common bile duct were left
out of the ROI. At the time of ROI placement, the operator
was aware of the location of the lesions and could refer to
routine MR images and to the histopathological diagnosis.
We examined patients with PC, mass-forming FP, and
without pancreatic disease. In three patients with mass-
forming FP and pancreatic pseudo cysts the ROI was
placed outside these cystic lesions. ADC values of the
control group were used to establish the normal values.
The ROI within each lesion was circular and placed on the
largest possible area, including necrotic parts. Mean ADCs
of the two lesion types and mean values of healthy pancrea-
tic tissue were compared.
Statistical analysis
The non-parametric Mann-Whitney U test was used to
determine whether there was a signiﬁcant difference
between ADC values for normal pancreas, PC, and mass-
forming FP. The degree of inter-observer agreement in
ADC value measurements was evaluated using the inter-
class correlation (ICC) coefﬁcient. An ICC value of less
than 0.40 indicates poor reproducibility, ICC values
between 0.40 to 0.75 indicate a fair to good reproducibility,
and an ICC value of greater than 0.75 shows excellent repro-
ducibility. All values were expressed as mean+SD, and a P
value of ,0.05 was considered statistically signiﬁcant. All
statistical analysis was performed using SPSS for
Windows, version 15.0 (SPSS Inc., Chicago, IL, USA).
Results
ADC measurements for all 24 PCs as well as the 20 mass-
forming FP showed lower ADC values compared to
normal pancreas parenchyma. The maximum tumor diam-
eter of PC ranged from 1.7 to 6.1 cm (mean 3.8 cm), the cor-
responding values for the mass-forming FP where 2.2 to
5 cm (mean 3.4 cm).
The corresponding ADC values (1023mm2/s) were as
follows: pancreatic carcinoma (n ¼ 24), 0.78+ 0.11.
Mass-forming FP (n ¼ 20), 0.69+ 0.18, and normal pancreas
in healthy volunteers (n ¼ 17), 0.17+ 0.06 (Table 1, Fig. 3).
ADC values of the pancreatic carcinoma proved to be
signiﬁcantly higher compared with those of the normal
pancreatic tissue in healthy volunteers (Table 2). The
Mann-Whitney U test demonstrated a statistically signiﬁ-
cant difference (P ,0.001). ADC values of the mass-forming
FP also proved to be signiﬁcantly higher compared with
those of the normal pancreatic tissue. The Mann-Whitney
U test demonstrated a statistically signiﬁcant difference
compared with those of the normal pancreatic tissue albeit
at a lower signiﬁcance level (P, 0.002). There was no sig-
niﬁcant difference in ADCs between PC and mass-forming
FP (P ¼ 0.15). The inter-observer agreement for ADC
measurements was analyzed using the ICC method. A
‘fair to good agreement’ was obtained for the average
ADC value of mass-forming FP (ICC ¼ 0.623). ‘Excellent’
inter-observer agreement was observed for the ADC
values of PC and the control group (ICC ¼ 0.768 and
ICC ¼ 0.823).
Table 1 Mean ADC values for normal pancreatic tissue, pancreatic
carcinoma, and mass-forming focal pancreatitis
Pancreatic disease n ADC values+ S.D.
None 17 0.17+0.06
Pancreatic carcinoma 24 0.78+0.11
Mass-forming FP 20 0.69+0.18
Data are mean (1023mm2/s)+ standard deviation
ADC ¼ apparent diffusion coefficient; FP ¼ focal pancreatitis
Fig. 2 A 56-year-old patient with mass-forming focal pancreatitis of the tail.
(a) T2-weighted axial MR image; (b) Axial ADC map calculated from basis
images obtained with b values of 50, 500 s/mm2 in the same patient clearly
shows the lesion. On the ADC map, higher diffusion is depicted as higher
signal intensity
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Discussion
Pancreatic cancer is the third most common malignancy of
the gastrointestinal tract; the incidence rate is estimated at
about 10 new cases per 100,000 people per year. The main
task in diagnostic imaging of the pancreas is the detection
and differentiation of pancreatic lesions into malignant
and benign (e.g. inﬂammatory) entities as well as to assess
resectability of pancreatic cancer. Usually morphologic
changes of chronic pancreatitis result in a shrunken and
atrophic pancreas, but occasionally it may present as a
mass-forming FP and thus may mimic a PC (12). This
may lead to a difﬁcult preoperative differential diagnosis.
Recent technical innovations have introduced diffusion-
weighted MR imaging with apparent diffusion coefﬁcient
(ADC) measurements. The usefulness of DWI with a single-
shot spin-echo echo-planar sequence (EPI) for the evalu-
ation of neoplastic diseases in the abdominal region has
been reported by several studies (4, 8, 19).
However, measured abdominal ADC values depend on
the exact selection of b values, in addition ADC values
also depend on the ﬁeld strength of the scanner (20).
There is a consistent decrease of ADC values with increased
diffusion weighting as well as with increased ﬁeld strength.
This might partially explain the variations of ADC values
for PC according to previous reports. Also the use of a
thin slice thickness of 2.6 mm for the DWI imaging and
the use of two b values as compared to the use multiple
b values have inﬂuenced the ADC measurements.
However, the use of a the thin slice thickness and two
b values did allow a rapid acquisition of images, albeit at
a low signal to noise ratio (SNR) of DWI images and thus
inﬂuencing the ADC values. PC has been associated with
decreased ADC values compared to healthy pancreatic
tissue due to the presence of ﬁbrosis and increased cellular-
ity which is associated with restricted water diffusion (13).
Necrosis is a common feature of PC and is associated with
increased ADC values due to increased motion of the
water protons in the tissue (21). Inﬂammation within and/
or surrounding the PC is also a common feature of larger
PC; this is due to the obstruction of the pancreatic duct or
its side branches (22, 23). Inﬂammatory processes correlate
with an increase of water diffusions, and thus have
increased ADC values (14). Yoshikawa et al. found signiﬁ-
cantly increased ADC values for PC compared to ADC
values for healthy pancreas parenchyma (18). Similarly,
we found increased ADC values for PC and mass-forming
FP compared to the pancreatic gland in the control group.
This might be due to the large lesions sizes (PC and mass-
forming FP) in our study compared to previous studies, as
these larger lesions are more commonly associated with
necrosis and inﬂammation. ADC values for the mass-
forming FP also proved to be signiﬁcantly higher compared
with those of the normal pancreatic tissue. However, there
was a signiﬁcant overlap in ADC values for PC and mass-
forming FP, with the consequent problem of their correct
differentiation. Chronic pancreatitis can also contain areas
of ﬁbrosis and focal inﬂammatory reactions (12), which
might explain the difﬁculty to differentiate these severe pan-
creatic lesions.
This study has some limitations, such as that the average
age of the patients was signiﬁcantly higher than that of our
healthy controls. This might have independently inﬂuenced
the measured ADC, however, the age range for the two
patient groups was comparable. Second, the patient and
control group were relatively small. Thus a statistically
signiﬁcant difference in ADC values might be established
in a larger sample. An additional limitation is that we
only analyzed the quantitative information of ADC maps,
leaving aside the qualitative information of the obtained
DWI images (24). Thus, we only evaluated the value of
ADC in differentiating PC, mass-forming FP, and normal
pancreas from each other. The additional information of
the original images with different b values has not been
used and the value of DWI in the detection and differen-
tiation has not been analyzed. Furthermore, we did not
evaluate ADC values of adjacent pancreas parenchyma
surrounding the lesion, which could have also yielded
extra information. Finally, the ROIs to acquire ADC values
covered the whole lesion including central necrosis. These
larger ROIs were used, to make the method feasible in the
daily clinical routine; however this might have biased the
measurement of ADCs in the patient group.
In conclusion, we could not demonstrate that using ADC
measurements of focal pancreatic lesions is a viable
Table 2 Mann-Whitney U test for differences in mean ADC values for
normal pancreatic tissue, pancreatic carcinoma, and mass-forming
focal pancreatitis
Parameter
Sample
sizes
Mann-Whitney
U
U P
Normal pancreas vs. pancreatic
carcinoma
n ¼ 17
n ¼ 24
13.5 ,0.001
Normal pancreas vs. mass-forming
FP
n ¼ 17
n ¼ 20
69.5 0.002
Pancreatic carcinoma vs.
mass-forming FP
n ¼ 24
n ¼ 20
179.0 0.15
P, 0.01
FP ¼ focal pancreatitis
Fig. 3 Box plots of ADC values for normal pancreatic tissue, pancreatic car-
cinoma, and mass-forming focal pancreatitis
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approach to differentiate between PC and mass-forming FP.
However, a differentiation of healthy pancreatic tissue from
PC and mass-forming FP was possible. Given the limited
accuracy of routine MRI (T1- and T2-weighted images) for
the differentiation of tumors, further studies are necessary
to investigate whether DWI can improve the accuracy of
MR imaging. Furthermore it remains to be seen if ADCs
can be used as an imaging response criteria for therapy
monitoring (5) and follow-up of palliative chemotherapy
in patients with metastatic or locally advanced inoperable
pancreatic cancer.
Conﬂict of interest: None.
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